ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.300
+$0.070 (+2.17%)
Day Range
$3.070 - $3.400
52 Week Range
$0.560 - $5.240
Volume
355.16K
Avg Volume (10D)
343.88K
Market Cap
$521.68M
Price Chart
Market Statistics
Open$3.210
Previous Close$3.230
Day High$3.400
Day Low$3.070
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap521.68M
Shares Outstanding158.08M
Price to Book17.57
Trading Activity
Volume355.16K
Value Traded1.15M
Bid$3.200 × 466
Ask$3.310 × 2,790
Performance
1 Day2.17%
5 Day6.45%
13 Week14.98%
52 Week297.59%
YTD-29.94%
Technical Indicators
RSI (14)40.90
50-Day SMA$3.959
200-Day SMA$2.396
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
